Indications
Symptomatic treatment of Parkinson’s disease as monotherapy or in combination with levodopa preparations in the late stage of the disease, when the effects of levodopa are weakened or become unstable and fluctuations in the therapeutic effect occur (on-off).
Reviews
There are no reviews yet